Moderna Uses A Combination Vaccine Against Covid Influenza And Rsv. Will It Work
Moderna is developing a three-in-one vaccine against COVID-19, influenza and RSV. The vaccine manufacturer is actively promoting the vaccine and hopes for regulatory approval next year. But without solid safety and efficacy data from clinical trials, it may never come to fruition. Moderna is actively promoting a combined vaccine against COVID-19, influenza and RSV, which targets three of the most serious respiratory diseases released each year with a single vaccine. But while a safe and effective vaccine would be welcome as Canada faces a increase in pediatric RSV casesstubbornly high COVID hospitalization and deaths and rises sharply flu cases, the drug company has not published data to support the vaccine’s safety or effectiveness....